<bill session="117" type="h" number="6710" updated="2022-12-30T04:18:56Z">
  <state datetime="2022-02-11">REFERRED</state>
  <status>
    <introduced datetime="2022-02-11"/>
  </status>
  <introduced datetime="2022-02-11"/>
  <titles>
    <title type="display">To direct the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to submit to Congress a report on barriers, including regulatory inefficiencies, to domestic manufacturing of active pharmaceutical ingredients, finished drug products, and devices, and for other purposes.</title>
    <title type="official" as="introduced">To direct the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to submit to Congress a report on barriers, including regulatory inefficiencies, to domestic manufacturing of active pharmaceutical ingredients, finished drug products, and devices, and for other purposes.</title>
  </titles>
  <sponsor bioguide_id="H001084"/>
  <cosponsors>
    <cosponsor bioguide_id="B001291" joined="2022-02-18"/>
    <cosponsor bioguide_id="B001299" joined="2022-02-11"/>
    <cosponsor bioguide_id="C001039" joined="2022-02-11"/>
    <cosponsor bioguide_id="C001104" joined="2022-02-11"/>
    <cosponsor bioguide_id="D000032" joined="2022-02-11"/>
    <cosponsor bioguide_id="G000552" joined="2022-02-11"/>
    <cosponsor bioguide_id="H001053" joined="2022-02-22"/>
    <cosponsor bioguide_id="H001082" joined="2022-02-11"/>
    <cosponsor bioguide_id="H001077" joined="2022-02-11"/>
    <cosponsor bioguide_id="H001067" joined="2022-02-11"/>
    <cosponsor bioguide_id="J000304" joined="2022-03-07"/>
    <cosponsor bioguide_id="K000395" joined="2022-02-11"/>
    <cosponsor bioguide_id="L000266" joined="2022-02-11"/>
    <cosponsor bioguide_id="M000871" joined="2022-02-15"/>
    <cosponsor bioguide_id="M001180" joined="2022-02-11"/>
    <cosponsor bioguide_id="M001211" joined="2022-02-11"/>
    <cosponsor bioguide_id="M001215" joined="2022-02-11"/>
    <cosponsor bioguide_id="M001195" joined="2022-03-24"/>
    <cosponsor bioguide_id="N000190" joined="2022-02-11"/>
    <cosponsor bioguide_id="S001189" joined="2022-02-11"/>
  </cosponsors>
  <actions>
    <action datetime="2022-02-11">
      <text>Introduced in House</text>
    </action>
    <action datetime="2022-02-11" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2022-02-14">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="117" type="h" number="4792" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Congressional oversight"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Emergency medical services and trauma care"/>
    <term name="Infectious and parasitic diseases"/>
    <term name="Manufacturing"/>
    <term name="Trade restrictions"/>
  </subjects>
  <amendments/>
  <summary date="2022-09-06T15:34:27Z" status="Introduced in House">This bill requires the Food and Drug Administration (FDA) to report to Congress on barriers to the domestic manufacturing of imported active pharmaceutical ingredients, finished drug products, and devices that are critical to public health.

The report must recommend strategies to overcome such barriers. The FDA may, to the extent appropriate, implement the strategies.</summary>
</bill>
